Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to 0.48%.

  • Ocular Therapeutix's Return on Capital Employed fell 900.0% to 0.48% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.48%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.46% for FY2025, which is 800.0% up from last year.
  • Ocular Therapeutix's Return on Capital Employed amounted to 0.48% in Q4 2025, which was down 900.0% from 0.66% recorded in Q3 2025.
  • Ocular Therapeutix's Return on Capital Employed's 5-year high stood at 0.23% during Q2 2024, with a 5-year trough of 0.9% in Q2 2023.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.48% (2025), whereas its average is 0.49%.
  • Per our database at Business Quant, Ocular Therapeutix's Return on Capital Employed surged by 9800bps in 2021 and then tumbled by -4100bps in 2023.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Return on Capital Employed stood at 0.42% in 2021, then plummeted by -52bps to 0.64% in 2022, then grew by 26bps to 0.48% in 2023, then rose by 17bps to 0.4% in 2024, then fell by -22bps to 0.48% in 2025.
  • Its Return on Capital Employed was 0.48% in Q4 2025, compared to 0.66% in Q3 2025 and 0.59% in Q2 2025.